Serial 88825068
Live / Registered — Registered (as of 19 Oct 2021)
What this means for you
Registered since 19 Oct 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88825068
- Registration number
- 6531596
- Mark type
- Design / logo
- Filed
- 06 Mar 2020
- Published for opposition
- 14 Jul 2020
- Registered
- 19 Oct 2021
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
Owner
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
Prosecution history
- 19 Oct 2021 — REGISTERED-PRINCIPAL REGISTER
- 14 Sept 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Sept 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Sept 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Aug 2021 — USE AMENDMENT FILED
- 08 Sept 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 Aug 2021 — TEAS STATEMENT OF USE RECEIVED
- 17 Jul 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jul 2021 — SOU EXTENSION 2 GRANTED
- 15 Jul 2021 — SOU EXTENSION 2 FILED
- 15 Jul 2021 — SOU TEAS EXTENSION RECEIVED
- 02 Feb 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Jan 2021 — SOU EXTENSION 1 GRANTED
- 29 Jan 2021 — SOU EXTENSION 1 FILED
- 29 Jan 2021 — SOU TEAS EXTENSION RECEIVED